13 Articles
13 Articles
UK’s Alliance Pharma accepts DBAY’s sweetened final offer
(Reuters) -Britain’s Alliance Pharma said on Monday it has agreed to a sweetened final cash proposal from asset management firm DBAY Advisors, valuing the healthcare group at about 362 million pounds ($467.5 million). The revised 64.75 pence-per-share proposal is a 3.6% increase from the previous bid of 62.5 pence, and represents a premium of 46% to the Alliance stock’s closing price on January 9, the day before the start of the offer period. In…
KKR-led consortium nears £1.6bn takeover of NHS landlord Assura
A consortium led by private equity giant KKR and infrastructure specialist Stonepeak Partners is on the verge of acquiring Assura, a major NHS landlord, in a deal valued at £1.6bn deal, marking another potential London-listed exit from the UK market, according to report by the Financial Times. KKR and Stonepeak have made a non-binding offer of 49.4p per share, representing a 32% premium to Assura’s closing price before KKR’s interest was first r…
Coverage Details
Bias Distribution
- 40% of the sources lean Left, 40% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage